Redness and Dry Eye Relief
- Manufacturer
- KC Pharmaceuticals, Inc
- Effective date
- 2025-12-21
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 01:28:40
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredients
Glycerin 0.25%
Naphazoline HCI 0.012%
OTC - PURPOSE SECTION
Active ingredients Purposes
Glycerin 0.25%........................................................Lubricant
Naphazoline HCI 0.012%........................................Redness reliever
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center
(1-800-222-1222) right away.
Inactive Ingredients
benzalkonium chloride, boric acid, edetate disodium,
purified water, sodium borate
DOSAGE & ADMINISTRATION SECTION
Directions:
instill 1 to 2 drops Ianthe affected eye(s) up to 4 times daily
INDICATIONS & USAGE SECTION
Uses
■ relieves redness of the eye due to minor eye irritations
■ for use as a protectant against further irritation or to relieve dryness of the eye
■ for the temporary relief of burning and irritation due to dryness of the eye
WARNINGS SECTION
Warnings
For external use only
Do not use if solution changes color or becomes cloudy
Ask a doctor before use if you have narrow angle glaucoma
When using this product
■ to avoid contamination, do not touch tip of container to any surface
■ replace cap after using
■ overuse may produce increased redness of the eye
■ pupils may become enlarged temporarily
Stop use and ask a doctor if
■ you experience eye pain
■ you experience changes in vision
■ you experience continued redness or irritation of the eye
■ the condition worsens or persists for more than 72 hours
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| GLYCERIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
Product Linked Resources#
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0194346489831 | GTIN-13: 0194346489831 EAN-13: 0194346489831 GTIN-12: 194346489831 UPC-A: 194346489831 GTIN storage (14 digits): 00194346489831 | Walmart_EDRL Final NDC 79903-362-01.jpg |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e18001c8-33ae-5f66-9cdc-a39724bd4573 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55651-620-01 | Redness and Dry Eye Relief | 15 mL in 1 BOTTLE | SOLUTION | 15 | 1 | |
| 55651-620-01 | Redness and Dry Eye Relief | 1 in 1 BOX | SOLUTION | 1 | 1 |
Products#
Every source-derived product name is available through these pages.
- Redness and Dry Eye Relief
- Glycerin, Naphazoline hydrochloride
- EDETATE DISODIUM
- BENZALKONIUM CHLORIDE
- SODIUM BORATE
- WATER
- GLYCERIN
- NAPHAZOLINE HYDROCHLORIDE
- NAPHAZOLINE
- BORIC ACID
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 55651-620 | 55651-620-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | IACT |
| SODIUM BORATE | 91MBZ8H3QO | IACT |
| WATER | 059QF0KO0R | IACT |
| GLYCERIN | PDC6A3C0OX | ACTIB |
| NAPHAZOLINE HYDROCHLORIDE | MZ1131787D | ACTIB |
| BORIC ACID | R57ZHV85D4 | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Redness and Dry Eye Relief | GLYCERIN, NAPHAZOLINE HYDROCHLORIDE | KC Pharmaceuticals, Inc | 4682f68d-6bdd-d860-e063-6394a90a2b52 | 2025-12-21 | Warnings | 55651-620-01 55651-620 55651062001 4682f69e-39ad-6a20-e063-6294a90a05a2 4682f68d-6bdd-d860-e063-6394a90a2b52 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
